Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report
SummaryEnzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Enzymotec Ltd (Enzymotec), a subsidiary of Frutarom Industries Ltd., produces, and markets of nutritional ingredients and medical foods for the entire human life-cycle such as from infancy to old age. The company develops clinically-validated products including bio-functional, lipid-based compounds compounds which meet a wide range of consumer demands on optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases. Its major products includes Infat, EnzyPS Solutions, Vayacog, Vayarin, Vayarol, NoctoPlex, LuciPlex, NoctoPlex for kids, and Addivance for kids. The company market products under Vayacog,INFAT,Vayarin, SHARP PS, SHARP PS GREEN,NOCTOPLEX, NOCTOPLEX for Kids, and LUCIPLEX brand names. The company has business presence in India, the US, China, and Sweden. Enzymotec is headquartered in Migdal HaEmek, Israel.
Scope
- Detailed information on Enzymotec Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Enzymotec Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Enzymotec Ltd including a breakdown and examination of key business segments
- Intelligence on Enzymotec Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Enzymotec Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons To Buy
- Gain understanding of Enzymotec Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Enzymotec Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Enzymotec Ltd's business structure, strategy and prospects.
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of health care products. The company's reportable segments are: established pharmaceutical products, which includes a range of generic pharmaceuticals; diagnostic products, which includes a range of diagnostic systems and tests; nutritional products, which includes a range of pediatric and adult nutritional products; and medical devices, which includes a range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices.
Danone is engaged in activities in the global food and beverages industry. Co. operates in four markets: Fresh Dairy Products (Co. produces and sells yogurts, fermented dairy products and other fresh dairy products); Waters (Co. produces and sells natural waters as well as flavored and vitamin-enriched waters products); Early Life Nutrition (Co. produces baby formula, milk-and fruit-based desserts, cereals, small pots of baby food and ready-made baby food); and Medical Nutrition (Co. develops adult and pediatric clinical nutrition products to be taken orally, or through a catheter in the event of malnutrition related to illness or other causes).
Neptune Technologies & Bioresources is engaged in the research, development and commercialization of products derived from marine biomasses for the nutraceutical, pharmaceutical and cosmetics industries. Co. focuses on the application of extraction processes on marine biomasses such as krill and other underexploited marine sources. Co. industrializes its extraction processes and produces its marine oil Neptune Krill Oil - NKO ® as well as its protein-concentrated Neptune Krill Aquatein - NKA™. Its products are intended for the nutraceutical, biopharmaceutical, cosmetics and pet food markets.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.